TY - JOUR AU - Bénézit, François AU - Le Bot, Audrey AU - Jouneau, Stéphane AU - Lemaître, Florian AU - Pronier, Charlotte AU - Lentz, Pierre-Axel AU - Patrat-Delon, Solène AU - Revest, Matthieu AU - Thibault, Vincent AU - Tattevin, Pierre T1 - COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020 T2 - Emerging Infectious Disease journal PY - 2020 VL - 26 IS - 10 SP - 2513 SN - 1080-6059 AB - Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations. KW - COVID-19 KW - 2019 novel coronavirus disease KW - hydroxychloroquine KW - plasma concentration KW - sarcoidosis KW - France KW - severe acute respiratory syndrome coronavirus 2 KW - SARS-CoV-2 KW - coronavirus KW - coronavirus disease KW - respiratory infections KW - viruses KW - zoonoses DO - 10.3201/eid2610.201816 UR - https://wwwnc.cdc.gov/eid/article/26/10/20-1816_article ER - End of Reference